Researchers have reported results from a phase 3 clinical trial for treating PTSD, or post-traumatic stress disorder, with a combination of psychotherapy and MDMA, a psychedelic drug referred to on the street as “molly,” or “ecstasy”.
The preliminary results indicate that the treatment works eve
Read the full story: https://is.gd/6SINxn